Medicine & Life Sciences
Receptor, Serotonin, 5-HT2B
100%
Idiopathic Pulmonary Fibrosis
75%
Pulmonary Fibrosis
56%
Lung
53%
Serotonin 5-HT2 Receptor Antagonists
52%
Serotonin
37%
Fibroblasts
31%
Extracellular Matrix
30%
Interstitial Lung Diseases
27%
Lung Diseases
19%
angiotensin converting enzyme 2
18%
Myofibroblasts
18%
Apoferritins
18%
Alveolar Epithelial Cells
16%
Transforming Growth Factors
15%
Fibrosis
15%
Bronchoconstriction
15%
Adventitia
15%
Cell- and Tissue-Based Therapy
13%
5-((4-(6-chlorothieno(2,3-d)pyrimidin-4-ylamino)piperidin-1-yl)methyl)-2-fluorobenzonitrile
11%
Basement Membrane
11%
Bleomycin
11%
Proteoglycans
11%
Mesenchymal Stem Cells
11%
Chronic Disease
10%
2-amino-4-(4-fluoronaphth-1-yl)-6-isopropylpyrimidine
9%
Hypoxia
9%
SARS Virus
9%
Decorin
9%
Proteins
8%
Biomarkers
8%
Systemic Scleroderma
7%
Serotonin 5-HT2 Receptors
7%
Collagen
6%
Ketanserin
6%
Smooth Muscle Myocytes
6%
Airway Remodeling
6%
Renin-Angiotensin System
6%
Global Health
6%
In Vitro Techniques
5%
Prostaglandins E
5%
Physics & Astronomy
fibrosis
43%
lungs
28%
fibroblasts
17%
biomarkers
16%
proteins
14%
basements
12%
interstitials
10%
actuators
10%
activation
9%
membranes
6%
matrices
5%